OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials
Sara Massironi, Federica Furfaro, Sarah Bencardino, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 9, pp. 761-787
Open Access | Times Cited: 7
Sara Massironi, Federica Furfaro, Sarah Bencardino, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 9, pp. 761-787
Open Access | Times Cited: 7
Showing 7 citing articles:
Chick Early Amniotic Fluid Alleviates Dextran-Sulfate-Sodium-Induced Colitis in Mice via T-Cell Receptor Pathway
Fan Chen, Yining Zhao, Yanfa Dai, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 51-51
Open Access | Times Cited: 1
Fan Chen, Yining Zhao, Yanfa Dai, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 51-51
Open Access | Times Cited: 1
Drug Development in Inflammatory Bowel Diseases: What Is Next?
Lorenzo Petronio, Arianna Dal Buono, Roberto Gabbiadini, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 190-190
Open Access
Lorenzo Petronio, Arianna Dal Buono, Roberto Gabbiadini, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 190-190
Open Access
Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine
Matthew B. Stanton, Mark A. Solinski, Stephen B. Hanauer
Expert Review of Clinical Immunology (2025), pp. 1-12
Closed Access
Matthew B. Stanton, Mark A. Solinski, Stephen B. Hanauer
Expert Review of Clinical Immunology (2025), pp. 1-12
Closed Access
Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics
Kazuo Yashima, Hiroki Kurumi, Naoyuki Yamaguchi, et al.
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Kazuo Yashima, Hiroki Kurumi, Naoyuki Yamaguchi, et al.
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis
Vipul Jairath, Tim Raine, Thomas P. Leahy, et al.
Journal of Comparative Effectiveness Research (2025)
Closed Access
Vipul Jairath, Tim Raine, Thomas P. Leahy, et al.
Journal of Comparative Effectiveness Research (2025)
Closed Access
The Expanding Therapeutic Potential of Deucravacitinib Beyond Psoriasis: A Narrative Review
Chul Hwan Bang, Chul Jong Park, Yoon‐Seob Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1745-1745
Open Access
Chul Hwan Bang, Chul Jong Park, Yoon‐Seob Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1745-1745
Open Access
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease
Sarah Bencardino, Cosimo Simone Matichecchia, Jacopo Fanizza, et al.
Autoimmunity Reviews (2024) Vol. 24, Iss. 2, pp. 103720-103720
Closed Access
Sarah Bencardino, Cosimo Simone Matichecchia, Jacopo Fanizza, et al.
Autoimmunity Reviews (2024) Vol. 24, Iss. 2, pp. 103720-103720
Closed Access
